Newsletter | November 26, 2019

11.26.19 -- Clinical Supply Chain: Innovations And Solutions

Innovative Clinical Supply Solutions: Cold Chain
A biopharmaceutical company known for the development of novel therapeutic drugs had a critical requirement to package a biohazardous frozen drug product. However, the client possessed no stability data at the project onset; an essential parameter in determining the need to keep the product frozen. Learn how the product was successfully packaged in sufficient quantity and on time for the Phase I trial.
Clinical Supply Chain Transformation Through Innovation
Even with forecasting and building out a sizeable buffer inventory, clinical sites may still not always have the appropriate kits on hand to dispense to patients. Why?
Achieve Continuous Supply Of Drug Treatment For Study Requirements
A small sized pharmaceutical company was approaching the final phases of a large phase III global multiple treatment arm oncology study that involved comparator drug. The study criteria required the client to provide study medication to patients active at the conclusion of the study until the drug would be commercially available, when it could then be prescribed to patients continuing treatment.
Comparator And Marketed Drug Sourcing Solutions

Catalent in-house pharmaceutical sourcing specialists utilize a global network of leading manufacturers, wholesalers, and carefully selected QA-qualified healthcare professionals to provide cost-effective access to virtually any product. When you use Catalent for pharmaceutical sourcing you get a global distribution network that can deliver what you need, where you need it, and when you need it. Always in the right condition.